Japanese encephalitis virus: changing the clinical landscape of encephalitis in Australia

Sarah Allen, Celia M Cooper, Ajay Taranath, Allen C Cheng and Philip N Britton
Med J Aust || doi: 10.5694/mja2.51905
Published online: 10 April 2023

A structured diagnostic approach is required when assessing for JEV in patients with encephalitis

The Japanese encephalitis virus (JEV) has been a long‐standing public health concern in Asia, where it is the most common cause of viral encephalitis in many countries. This mosquito‐borne flavivirus is transmitted to humans from reservoirs in pigs and waterbirds. Subsequent acute encephalitis occurs in less than 1% of people infected, but when it does, it often results in death or significant neurological disability. The effectiveness of population‐wide immunisation programs in reducing the disease burden of Japanese encephalitis is well established.1,2

  • 1 Women's and Children's Hospital, Adelaide, SA
  • 2 University of Adelaide, Adelaide, SA
  • 3 Monash University, Melbourne, VIC
  • 4 University of Sydney, Sydney, NSW
  • 5 Children's Hospital at Westmead, Sydney, NSW


Competing interests:

No relevant disclosures.

  • 1. World Health Organization. Measuring effectiveness and impact of Japanese encephalitis vaccination. WHO, 2016.‐IVB‐16.03‐eng.pdf (viewed Sept 2022).
  • 2. World Health Organization. Manual for the laboratory diagnosis of Japanese encephalitis virus infection — for evaluation purposes. WHO, 2007.‐source/immunization/vpd_surveillance/lab_networks/manual‐lab‐diagnosis‐je.pdf?sfvrsn=e2b62a35_4 (viewed Nov 2022).
  • 3. Australian Government, Department of Health and Aged Care. Japanese encephalitis virus (JEV) [website]. Canberra: Commonwealth of Australia, 2022.‐alerts/japanese‐encephalitis‐virus‐jev/about#current‐status (viewed Oct 2022).
  • 4. Department of Health Victoria. Japanese encephalitis virus [website]. Melbourne: State of Victoria, 2022.‐diseases/information‐for‐health‐professionals‐japanese‐encephalitis‐in‐victoria#vaccination (viewed Sept 2022).
  • 5. Pham D, Howard‐Jones AR, Hueston L, et al. Emergence of Japanese encephalitis in Australia: a diagnostic perspective. Pathology 2022; 54: 669‐677.
  • 6. Solomon T, Webb C, Friedman D, Macartney K. Sydney ID Distinguished Lecture Series: JEV outbreak in Australia — important insights for clinicians. Sydney: Institute for Infectious Diseases, 2022 (viewed Sept 2022).
  • 7. Turtle L, Solomon T. Japanese encephalitis — the prospects for new treatments. Nat Rev Neurol 2018; 14: 298‐313.
  • 8. Britton PN, Eastwood K, Paterson B, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J 2015; 45: 563‐576.
  • 9. Handique SK, Das RR, Barman K, et al. Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis. Am J Neuroradiol 2006; 27: 1027‐1031.
  • 10. Atlas SW; editor. Magnetic resonance imaging of the brain and spine, 3rd ed. Philadelphia: Lippincott Williams and Wilkins, 2002; pp. 1099‐1175.
  • 11. Howard‐Jones AR, Pham D, Jeoffreys N, et al. Emerging genotype IV Japanese encephalitis virus outbreak in New South Wales, Australia. Viruses 2022; 14: 1853.
  • 12. Moore CE, Blacksell SD, Taojaikong T, et al. A prospective assessment of the accuracy of commercial IgM ELISAs in diagnosis of Japanese encephalitis virus infections in patients with suspected central nervous system infections in Laos. Am J Trop Med Hyg 2012; 87: 171‐178.
  • 13. Dubot‐Pérès A, Sengvilaipaseuth O, Chanthongthip A, et al. How many patients with anti‐JEV IgM in cerebrospinal fluid really have Japanese encephalitis? Lancet Infect Dis 2015; 15: 1376‐1377.
  • 14. Swami R, Ratho RK, Mishra B, Singh M. Usefulness of RT‐PCR for the diagnosis of Japanese encephalitis in clinical samples. Scand J Infect Dis 2008; 40: 815‐820.
  • 15. Huang GKL, Tio SY, Caly L, et al. Prolonged detection of Japanese encephalitis virus in urine and whole blood in a returned short‐term traveler. Open Forum Infect Dis 2017; 4: ofx203.
  • 16. Bharucha T, Sengvilaipaseuth O, Seephonelee M, et al. Viral RNA degradation makes urine a challenging specimen for detection of Japanese encephalitis virus in patients with suspected CNS infection. Open Forum Infect Dis 2019; 6: ofz048.
  • 17. Bharucha T, Sengvilaipaseuth O, Seephonelee M, et al. Detection of Japanese encephalitis virus RNA in human throat samples in Laos — a pilot study. Sci Rep 2018; 8: 8018.
  • 18. NSW Health. Summary of NSW Japanese encephalitis virus serosurvey results. Sydney: NSW Health, 2022.‐serosurvey‐report.pdf (viewed Sept 2022).
  • 19. Australian Government, Department of Health and Aged Care. CDNA advice regarding vaccination against Japanese encephalitis virus [website]. Canberra: Commonwealth of Australia, 2022.‐advice‐regarding‐vaccination‐against‐japanese‐encephalitis‐virus (viewed Sept 2022).
  • 20. Australian Government, Department of Health and Aged Care. ATAGI clinical guidance on Japanese encephalitis virus vaccines [website]. Canberra: Commonwealth of Australia, 2022.‐alerts/japanese‐encephalitis‐virus‐jev/clinical‐guidance#:~:text=JE%20vaccination%20is%20suitable%20for,high%20risk%20settings%20in%20Australia (viewed Sept 2022).
  • 21. NSW Health. NSW expands access to Japanese encephalitis vaccine [media release]. 14 Sept 2022. (viewed Sept 2022).
  • 22. Trujillo‐Gómez J, Tsokani S, Arango‐Ferreira C, et al. Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta‐analysis. EclinicalMedicine 2022; 44: 101275.
  • 23. Perlejewski K, Bukowska‐Ośko I, Rydzanicz M, et al. Next‐generation sequencing in the diagnosis of viral encephalitis: sensitivity and clinical limitations. Sci Rep 2020; 10: 16173.
  • 24. Xu GJ, Kula T, Xu Q, et al. Comprehensive serological profiling of human populations using a synthetic human virome. Science 2015; 348: aaa0698.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.